Inhalation Injury Treatment & Management

  • Author: Denise Serebrisky, MD; Chief Editor: Michael R Bye, MD   more...
 
Updated: May 25, 2010
 

Medical Care

Decision to admit

Evaluate patients who present with inhalation injury for the extent of disease and degree of hypoxemia. A child who is at low risk for injury with no clinical symptoms can usually be observed for 4-12 hours and discharged with close follow-up and instructions to return if symptomatic.

Observe the high-risk child with only minimal symptoms for 4-12 hours and, if any symptoms or concerns arise, admit to the hospital for further observation and oxygenation monitoring.

The symptomatic child with any signs of airway obstruction, bronchospasm, respiratory distress, or concurrent burns is admitted to the hospital for appropriate monitoring because edema and obstruction typically worsen over the next 24-48 hours.

Airways

Ensure patency and stability. Check for exposure to heat and thermal injury to the nose, mouth, face, and singed hair. Consider smoke involvement if soot is on the face and in sputum, although smoke inhalation is possible without evidence of soot.

Direct laryngoscopy and fiberoptic endoscopy are useful to evaluate the extent of airway edema and burns, although vasoconstriction from hypovolemia may result in underappreciation of the severity of injury. When upper airway injury is suspected, elective intubation should be considered because progression of edema over the next 24-48 hours may make later intubation difficult if not impossible.

Breathing

Check for upper airway compromise, difficulty breathing, stridor, cough, retractions, and bilateral breath sounds. Administer 100% oxygen because of the likelihood of CO inhalation in fires.

The direct effects of inhalation injury are usually evident within 24 hours, although late pulmonary dysfunction may result from complex hemodynamic and infectious complications associated with surface burns.

Circulation

Patients whose injury involves cutaneous burns have ongoing circulatory derangements. Fluid loss through burned areas from intense inflammation with vasodilatation and capillary leak or from the subsequent infectious complications necessitates large fluid volume resuscitation. Even minor errors in estimation of body surface area; burned surface area; and fluid, electrolyte, and protein requirements can produce profound hemodynamic and respiratory embarrassment.

Large-bore intravenous catheter access may be needed to facilitate fluid resuscitation. Frequent evaluation of heart rate, perfusion, and blood pressure are needed to determine stability and guide therapy.

Neurology

Patient responsiveness helps determine the ability to protect the airway and is also an excellent indicator of adequacy of resuscitation success.

The neurologic examination is frequently clouded by hypoxic and toxic neurologic injury and the necessary use of potent analgesics.

Burns

Check all body areas for additional injury and burns. Wash unburned skin to remove any remaining toxic residues.

Medications

Corticosteroids are attractive for suppressing inflammation and reducing edema. Controlled studies assessing their effects on various forms of chemical pneumonitis are disappointing, and no direct data support their use in smoke inhalation. Because of the increased risk of infection and delayed wound healing, prolonged use of steroids is discouraged. Studies report increased incidence of pulmonary infection and mortality in patients receiving steroids. However, consider a brief course of steroids in those patients with otherwise unresponsive severe lower airway obstruction. In addition, patients receiving steroids prior to injury who may experience adrenal insufficiency should receive stress doses of steroids.

Patients with pulmonary damage from inhalation injury are at increased risk for secondary bacterial infection. The most common organisms are Staphylococcus aureus and Pseudomonas aeruginosa. Direct parenteral coverage with antibiotics to cover these bacteria if infection is suspected.

Antimicrobial therapy should be reserved for patients with definitive microbiologic evidence of infection that is not responding to aggressive support therapy or when clinical deterioration occurs in the first 72 hours, when infection is most likely to occur. Prophylactic antibiotics are not only nonprophylactic, but increase the risk of emergence of resistant organisms. Discerning secondary infection from the effects of inhalation injury can be very difficult because both may produce fever, elevated WBC counts, and abnormal radiography findings.

Although pulmonary damage includes inactivation of surfactant, the effectiveness of artificial surfactant administration has not been proven.

Cyanide is detoxified to thiocyanate (SCN-), predominately by rhodanese in the liver. Thiocyanate is excreted by the kidneys in the presence of normal renal function. Rhodanese is located around the mitochondria within the cells, placing it in close proximity to the major site of cyanide toxicity, the cytochrome oxidases. Sulfur is required for this enzymatic process to occur.

Oxygen and sodium thiosulfate are the most widely accepted cyanide antidotes. Less accepted cyanide antidotes include hydroxocobalamin and dicobalt ethylenediaminetetraacetic acid (EDTA). The mechanism of action of oxygen as a cyanide antidote is unclear but it potentiates the effect of other antidotes. When used in the setting of smoke inhalation, it is also therapeutic for CO poisoning. Thus, high concentrations of oxygen should be promptly delivered.

Sodium thiosulfate increases the sulfur pool and dramatically favors conversion of cyanide to thiocyanate. In the presence of renal failure, thiocyanate is not eliminated and hemodialysis should be offered.

Nitrites convert hemoglobin to methemoglobin. Cyanide becomes bound to methemoglobin because of its very high affinity for the ferric iron of methemoglobin. The induction of methemoglobinemia in the setting of smoke inhalation should be undertaken with caution because coexisting carboxyhemoglobinemia can seriously decrease oxygen carrying capacity and is potentially dangerous.

Antidote kits (eg, Lily Cyanide Antidote Kit) that include amyl nitrite, sodium nitrite, and sodium thiosulfate are commercially available.

Bronchodilators are used in those patients with bronchoconstriction. Intravenous bronchodilators may be needed in severe cases. See Medication for specific instructions.

Heparin has been administered topically, subcutaneously, intravenously, or via aerosol in several studies.[6] Currently, no strong evidence suggests that heparin can improve clinical outcomes in the treatment of burn injuries.

Oxygen

Oxygen is used in cases with significant inhalation injury. See Medication for specific instructions.

Next

Surgical Care

A team experienced in caring for children with burns should evaluate children with significant cutaneous burns.

Previous
Next

Consultations

A pediatric pulmonologist, surgeon, or otolaryngologist should be consulted to perform direct laryngoscopy or bronchoscopy if needed. A pediatric pulmonologist is needed for children suspected of having residual pulmonary disease.

Previous
Next

Diet

Do not feed children by mouth until significant respiratory or hemodynamic compromise clearly does not require tracheal intubation.

Even with extensive burns, most patients can tolerate enteral feedings at the end of the first 24 hours. Begin enteral feedings as soon as possible. As enteral intake increases, decrease intravenous fluids accordingly. Patients may demonstrate marked hypermetabolism. Therefore, providing adequate nutritional support is important.

Previous
Next

Activity

Activity is performed as tolerated and as dictated by the extent of disease.

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Denise Serebrisky, MD  Assistant Professor, Department of Pediatrics, Albert Einstein College of Medicine; Director, Division of Pulmonary Medicine, Lewis M Fraad Department of Pediatrics, Jacobi Medical Center; Director, Jacobi Asthma and Allergy Center for Children

Denise Serebrisky, MD is a member of the following medical societies: American Thoracic Society

Disclosure: Nothing to disclose.

Coauthor(s)

Emily B Nazarian, MD  MD, Assistant Professor of Pediatrics, Fellowship Director, Pediatric Critical Care, Golisano Children's Hospital at Strong

Emily B Nazarian, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Heidi Connolly, MD  Associate Professor of Pediatrics and Psychiatry, University of Rochester; Director, Pediatric Sleep Medicine Services, Strong Sleep Disorders Center

Heidi Connolly, MD is a member of the following medical societies: American Academy of Pediatrics, American Thoracic Society, and Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Girish D Sharma, MD  Associate Professor of Pediatrics, Rush Medical College; Director, Section of Pediatric Pulmonology and Rush Cystic Fibrosis Center, Rush University Medical Center

Girish D Sharma, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American Thoracic Society, and Royal College of Physicians of Ireland

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Charles Callahan, DO  Professor, Deputy Chief of Clinical Services, Walter Reed Army Medical Center

Charles Callahan, DO is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American College of Osteopathic Pediatricians, American Thoracic Society, Association of Military Surgeons of the US, and Christian Medical & Dental Society

Disclosure: Nothing to disclose.

Mary E Cataletto, MD  Associate Director, Division of Pediatric Pulmonology, Winthrop University Hospital; Professor of Clinical Pediatrics, State University of New York at Stony Brook; Director of Children's Sleep Services, Winthrop University Hospital

Mary E Cataletto, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Chest Physicians

Disclosure: Shering Plough Pharmaceuticals Honoraria Consulting

Chief Editor

Michael R Bye, MD  Professor of Clinical Pediatrics, Division of Pulmonary Medicine, Columbia University College of Physicians and Surgeons; Attending Physician, Pediatric Pulmonary Medicine, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University Medical Center

Michael R Bye, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, and American Thoracic Society

Disclosure: Nothing to disclose.

References
  1. Whitelock-Jones L, Bass DH, Millar AJ, Rode H. Inhalation burns in children. Pediatr Surg Int. 1999;15(1):50-5. [Medline].

  2. Rorison DG, McPherson SJ. Acute toxic inhalations. Emerg Med Clin North Am. May 1992;10(2):409-35. [Medline].

  3. Weiss SM, Lakshminarayan S. Acute inhalation injury. Clin Chest Med. Mar 1994;15(1):103-16. [Medline].

  4. Carr JA, Phillips BD, Bowling WM. The utility of bronchoscopy after inhalation injury complicated by pneumonia in burn patients: results from the National Burn Repository. J Burn Care Res. Nov-Dec 2009;30(6):967-74. [Medline].

  5. Agee RN, Long JM 3rd, Hunt JL, Petroff PA, Lull RJ, Mason AD Jr, et al. Use of 133xenon in early diagnosis of inhalation injury. J Trauma. Mar 1976;16(3):218-24. [Medline].

  6. Oremus M, Hanson MD, Whitlock R, Young E, Archer C, Dal Cin A, et al. A systematic review of heparin to treat burn injury. J Burn Care Res. Nov-Dec 2007;28(6):794-804. [Medline].

  7. Jones WG, Madden M, Finkelstein J, Yurt RW, Goodwin CW. Tracheostomies in burn patients. Ann Surg. Apr 1989;209(4):471-4. [Medline]. [Full Text].

  8. Bartlett RH. Critical Care Physiology. Little, Brown and Company: Boston, Mass; 1996:68-69.

  9. Blanc PD, Galbo M, Hiatt P, Olson KR, Balmes JR. Symptoms, lung function, and airway responsiveness following irritant inhalation. Chest. Jun 1993;103(6):1699-705. [Medline].

  10. Chou KJ, Fisher JL, Silver EJ. Characteristics and outcome of children with carbon monoxide poisoning with and without smoke exposure referred for hyperbaric oxygen therapy. Pediatr Emerg Care. Jun 2000;16(3):151-5. [Medline].

  11. Clark CJ, Campbell D, Reid WH. Blood carboxyhaemoglobin and cyanide levels in fire survivors. Lancet. Jun 20 1981;1(8234):1332-5. [Medline].

  12. Cohen MA, Guzzardi LJ. Inhalation of products of combustion. Ann Emerg Med. Oct 1983;12(10):628-32. [Medline].

  13. Demarest GB, Hudson LD, Altman LC. Impaired alveolar macrophage chemotaxis in patients with acute smoke inhalation. Am Rev Respir Dis. Feb 1979;119(2):279-86. [Medline].

  14. DiVincenti FC, Pruitt BA Jr, Reckler JM. Inhalation injuries. J Trauma. Feb 1971;11(2):109-17. [Medline].

  15. Haponik EF, Crapo RO, Herndon DN, Traber DL, Hudson L, Moylan J. Smoke inhalation. Am Rev Respir Dis. Oct 1988;138(4):1060-3. [Medline].

  16. Heimbach DM, Waeckerle JF. Inhalation injuries. Ann Emerg Med. Dec 1988;17(12):1316-20. [Medline].

  17. Jackson MP, Philp B, Murdoch LJ, Powell BW. High frequency oscillatory ventilation successfully used to treat a severe paediatric inhalation injury. Burns. Aug 2002;28(5):509-11. [Medline].

  18. Juurlink DN, Buckley NA, Stanbrook MB, Isbister GK, Bennett M, McGuigan MA. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev. Jan 25 2005;CD002041. [Medline].

  19. Kipen HM, Rab S, Mohr S. Incidence of persistent symptoms and morbidity after inhalation exposure. American Review of Respiratory Disease. 1993;147:A113.

  20. Madnani DD, Steele NP, de Vries E. Factors that predict the need for intubation in patients with smoke inhalation injury. Ear Nose Throat J. Apr 2006;85(4):278-80. [Medline].

  21. Moritz AR, Henriques FC, McLean R. The effects of inhaled heat on the air passages and lungs: an experimental investigation. American Journal of Pathology. 1945;21:311-325.

  22. Peterson JE, Stewart RD. Absorption and elimination of carbon monoxide by inactive young men. Arch Environ Health. Aug 1970;21(2):165-71. [Medline].

  23. Pruitt BA Jr, Cioffi WG, Shimazu T, Ikeuchi H, Mason AD Jr. Evaluation and management of patients with inhalation injury. J Trauma. Dec 1990;30(12 Suppl):S63-8. [Medline].

  24. Pruitt BA Jr, Erickson DR, Morris A. Progressive pulmonary insufficiency and other pulmonary complications of thermal injury. J Trauma. May 1975;15(5):369-79. [Medline].

  25. Rossignol AM, Boyle CM, Locke JA, Burke JF. Hospitalized burn injuries in Massachusetts: an assessment of incidence and product involvement. Am J Public Health. Nov 1986;76(11):1341-3. [Medline].

  26. Ruddy RM. Smoke inhalation injury. Pediatr Clin North Am. Apr 1994;41(2):317-36. [Medline].

  27. Stone JP, Hazlett RN, Johnson JE. The transport of hydrogen chloride by soot from burning polyvinyl chloride. J of Fire Flammability. 1973;4:42.

  28. Thom SR, Keim LW. Carbon monoxide poisoning: a review epidemiology, pathophysiology, clinical findings, and treatment options including hyperbaric oxygen therapy. J Toxicol Clin Toxicol. 1989;27(3):141-56. [Medline].

  29. Vogel SN, Sultan TR, Ten Eyck RP. Cyanide poisoning. Clin Toxicol. Mar 1981;18(3):367-83. [Medline].

  30. Weaver LK, Hopkins RO, Chan KJ, Churchill S, Elliott CG, Clemmer TP, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med. Oct 3 2002;347(14):1057-67. [Medline].

  31. Whitener DR, Whitener LM, Robertson KJ, Baxter CR, Pierce AK. Pulmonary function measurements in patients with thermal injury and smoke inhalation. Am Rev Respir Dis. Nov 1980;122(5):731-9. [Medline].

  32. Witten ML, Quan SF, Sobonya RE, Lemen RJ. New developments in the pathogenesis of smoke inhalation-induced pulmonary edema. West J Med. Jan 1988;148(1):33-6. [Medline]. [Full Text].

  33. Wright MJ, Murphy JT. Smoke inhalation enhances early alveolar leukocyte responsiveness to endotoxin. J Trauma. Jul 2005;59(1):64-70. [Medline].

  34. Zikria BA, Weston GC, Chodoff M, Ferrer JM. Smoke and carbon monoxide poisoning in fire victims. J Trauma. Aug 1972;12(8):641-5. [Medline].

Previous
Next
 
Table. Inhalants[2, 3]
TypeInhalantSourceInjury/Mechanism
Irritant gasesAmmoniaFertilizer, refrigerant, manufacturing of dyes, plastics, nylonUpper airway epithelial damage
ChlorineBleaching agent, sewage and water disinfectant, cleansing productsLower airway epithelial damage
Sulfur dioxideCombustion of coal, oil, cooking fuel, smeltingUpper airway epithelial damage
Nitrogen dioxideCombustion of diesel, welding, manufacturing of dyes, lacquers, wall paperTerminal airway epithelial damage
AsphyxiantsCarbon monoxide*Combustion of weeds, coal, gas, heatersCompetes for oxygen sites on hemoglobin, myoglobin, heme-containing intracellular proteins
Hydrogen cyanideBurning of polyurethane, nitrocellulose (silk, nylon, wool)Tissue asphyxiation by inhibiting intracellular cytochrome oxidase activity, inhibits ATP production, leads to cellular anoxia
Hydrogen sulfideSewage treatment facility, volcanic gases, coal mines, natural hot springsSimilar to cyanide, tissue asphyxiant by inhibition of cytochrome oxidase, leads to disruption of electron transport chain, results in anaerobic metabolism
Systemic toxinsHydrocarbonsInhalant abuse (toluene, benzene, Freon); aerosols; glue; gasoline; nail polish remover; typewriter correction fluid; ingestion of petroleum solvents, kerosene, liquid polishes CNS narcosis, anesthetic stats, diffuse GI symptoms, peripheral neuropathy with weakness, coma, sudden death, chemical pneumonitis, CNS abnormalities, GI irritation, cardiomyopathy, renal toxicity
OrganophosphatesInsecticides, nerve gasesBlocks acetylcholinesterase, cholinergic crisis with increased acetylcholine
Metal fumesMetal oxides of zinc, copper, magnesium, jewelry makingFlulike symptoms, fever, myalgia, weakness
* Major component of smoke



† Smells like almonds, component of smoke from fires



‡ Smells like rotten eggs



Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.